ArticleFrontiers in endocrinology2025

Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study.

Ming Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.